Barbour Foundation PhD studentship in Cancer - Unravelling inequalities in access to targeted therapy for the treatment of breast and lung cancer across England and Sweden

Newcastle University - School of Pharmacy

All students - Postgraduate - Newcastle University Value of award

100% of UK/EU tuition fees paid and annual living expenses of £14,777 (full award). Successful international candidates will be required to make up the difference between the UK/EU fees and international fees.

Number of awards 1

Start date and duration September 2018 for 3 years.

Overview

Recent advances in oncology have seen the advent of molecular targeted therapeutics personalised to tumour characteristics. These developments have changed how many common cancers, such as breast and lung cancer, are now managed.

Given that targeted therapies are considerably more expensive than traditional chemotherapies, and that there increased availability is likely to result in an increase in drug utilisation, it is imperative that the prescribing of these therapies is well understood.

This PhD programme of work will investigate the utilisation of targeted therapies for the treatment of breast and lung cancer across England and Sweden, and explore how the utilisation varies according to age and socioeconomic factors.

This project represents an exciting opportunity working with the disciplines of pharmaceutical public health, oncology, and cancer epidemiology.

The PhD student will be based at the School of Pharmacy, Newcastle University, and will also have opportunity to spend time at the Ageing Research Centre, Karolinska Institutet, Stockholm, to analyse the Swedish data. The successful candidate will be provided with full training and the necessary support in quantitative methods.

Sponsor

Newcastle University, Faculty of Medical Sciences.

Name of supervisor(s)

Dr Adam Todd, School of Pharmacy
Professor Linda Sharp, Institute of Health and Society
Dr Alastair Greystoke, Northern Institute of Cancer Research
Professor Kristina Johnell, Aging Research Centre, Karolinska Institutet,  

Eligibility Criteria

You must have, or expect to achieve, at least a 2:1 Honours degree in a relevant subject area. A further qualification such as an MSc or MRes is advantageous. The PhD would be especially suitable for someone with some knowledge, training or experience of quantitative data analysis

This award is available to UK/EU and international applicants.  

To study this course you need to meet the following English Language requirements: IELTS 6.5 overall (with a minimum of 5.5 in all other sub-skills).  

How to apply

You must apply through the University’s online postgraduate application system. To do this please ‘Create a new account’.  

Only mandatory fields need to be completed. However, you will need to include the following information: 

  • Insert the programme code 8300F in the programme of study section  
  • Select ‘PhD in the Faculty of Medical Sciences (full time) – Pharmacy’ as the programme of study 
  • Insert the studentship code HS031 in the studentship/partnership reference field attach a covering letter and CV. The covering letter must state the title of the studentship, quote the studentship reference code HS031 and state how your interests and experience relate to the project  
  • Attach degree transcripts and certificates and, if English is not your first language, a copy of your English language qualifications.  

Our Postgraduate Admissions Service will then forward this information to the relevant selector in the Faculty of Medical Sciences. 

Contact

Dr Adam Todd
School of Pharmacy
e-mail: adam.todd@newcastle.ac.uk
Telephone: +44 (0) 191 208 2355

Share this PhD
     
  Share by Email   Print this job   More sharing options
We value your feedback on the quality of our adverts. If you have a comment to make about the overall quality of this advert, or its categorisation then please send us your feedback
Advert information

Type / Role:

PhD

Location(s):

Northern England